Home Table of Contents

§ 2-802. Price gouging in sale of an essential off-patent or generic drug prohibited

West's Annotated Code of MarylandHealth--GeneralEffective: October 1, 2017

West's Annotated Code of Maryland
Health--General
Title 2. Maryland Department of Health (Refs & Annos)
Subtitle 8. Prohibition Against Price Gouging for Essential Off-Patent or Generic Drugs (Refs & Annos)
Effective: October 1, 2017
MD Code, Health - General, § 2-802
§ 2-802. Price gouging in sale of an essential off-patent or generic drug prohibited
In general
(a) A manufacturer or wholesale distributor may not engage in price gouging in the sale of an essential off-patent or generic drug.
Price increase
(b) It is not a violation of subsection (a) of this section for a wholesale distributor to increase the price of an essential off-patent or generic drug if the price increase is directly attributable to additional costs for the drug imposed on the wholesale distributor by the manufacturer of the drug.

Credits

Added by Acts 2017, c. 818, § 1, eff. Oct. 1, 2017.
MD Code, Health - General, § 2-802, MD HEALTH GEN § 2-802
Current with all legislation from the 2021 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document